Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Everolimus is effective in the treatment
and prevention of chronic graft dysfunction and chronic graft rejection after lung
transplantation.